Comparison Chart Charles River Laboratories International, Inc. CBOE
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
CBOE
15:59:50 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 295.33 USD | +1.32% |
|
+3.67% | +45.99% |
| 08-20 | Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing | MT |
| 08-20 | Charles River, Medigen Partner on Multivalent Enterovirus Vaccine | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Other Biotechnology & Medical Research | +1.32% | +3.67% | - | - | - | 13.91B |
-
|
-
|
-
|
Select your edition
All financial news and data tailored to specific country editions
